These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11797239)

  • 21. Symposium on prions and transfusion safety.
    Coste J
    Transfus Clin Biol; 2013 Sep; 20(4):393-4. PubMed ID: 23928184
    [No Abstract]   [Full Text] [Related]  

  • 22. Variant Creutzfeldt-Jakob disease in an Italian woman.
    La Bella V; Collinge J; Pocchiari M; Piccoli F
    Lancet; 2002 Sep; 360(9338):997-8. PubMed ID: 12383671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A bloody mess. New safeguards will cut supplies of a lifesaving resource.
    Sobel RK
    US News World Rep; 2001 Sep; 131(8):36-9. PubMed ID: 11550392
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk of transmission of Creutzfeldt-Jakob disease via blood and blood products. The French risk-analysis over the last 15 years.
    Martin M; Trouvin JH
    Transfus Clin Biol; 2013 Sep; 20(4):398-404. PubMed ID: 23910008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prions and transfusion medicine.
    Budka H
    Vox Sang; 2000; 78 Suppl 2():231-8. PubMed ID: 10938959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Creutzfeldt-Jakob disease and transfusion].
    Saura C
    Ann Biol Clin (Paris); 2001 Oct; 59 Spec No():23-4. PubMed ID: 11675288
    [No Abstract]   [Full Text] [Related]  

  • 27. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
    Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
    Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products.
    Zaman SM; Hill FG; Palmer B; Millar CM; Bone A; Molesworth AM; Connor N; Lee CA; Dolan G; Wilde JT; Gill ON; Makris M
    Haemophilia; 2011 Nov; 17(6):931-7. PubMed ID: 21342369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Batch recall of French plasma-derived products due to variant Creutzfeldt-Jakob disease risk: the psychological impact on haemophilic patients, changes in their therapeutic demands and behaviour and ethical considerations.
    Aouba A; Harroche A; Frenzel L; Torchet MF; Rothschild C; François I; Mamzer-Bruneel MF
    Haemophilia; 2015 Jan; 21(1):27-33. PubMed ID: 25545300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International views on universal leucodepletion: the perspective in Portugal.
    de Sousa G
    Transfus Sci; 1998 Dec; 19(4):351-2. PubMed ID: 10351152
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease: a European perspective.
    Domanović D; Lewin A; O'Leary P; Janner-Jametti T; El Dusouqui SA; Sousa AP; Zaaijer H; Roberts B; Bougard D; Prati D; Nordberg J; Erikstrup C; Janssen M; Lieshout-Krikke R; Gubbe K; O'Flaherty N; Mathy G; Chantillon AM; Lehtisalo R; Sørensen ØH; Tiberghien P; Thomas S
    Blood Transfus; 2024 Sep; 22(5):415-419. PubMed ID: 38814884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood supplies hit by vCJD fear.
    Strachan-Bennett S
    Nurs Times; 2004 Jan 6-12; 100(1):6. PubMed ID: 14735624
    [No Abstract]   [Full Text] [Related]  

  • 33. Lessons from the response to the threat of transfusion-transmitted vCJD in Ireland.
    Murphy WG
    Transfus Clin Biol; 2013 Sep; 20(4):416-21. PubMed ID: 24001606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International views on universal leucodepletion: the perspective in NBS, England.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):347-8. PubMed ID: 10351150
    [No Abstract]   [Full Text] [Related]  

  • 35. Variant Creutzfeldt-Jakob disease and the Quebec blood supply.
    Germain M; Décary F; Chiavetta J; Goldman M
    CMAJ; 2000 Aug; 163(4):412-3. PubMed ID: 10976257
    [No Abstract]   [Full Text] [Related]  

  • 36. Blood-transmitted prions and variant Creutzfeldt-Jakob disease.
    Grady GF; Vyas GN
    Biologicals; 2007 Apr; 35(2):75-7. PubMed ID: 17317213
    [No Abstract]   [Full Text] [Related]  

  • 37. [Creutzfeldt-Jakob disease: what's new?].
    Brandel JP
    Rev Prat; 2007 Oct; 57(16):1745-7. PubMed ID: 18092714
    [No Abstract]   [Full Text] [Related]  

  • 38. Transfusion transmission of human prion diseases.
    Zou S; Fang CT; Schonberger LB
    Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of variant CJD on transfusion practices in the UK.
    Boulton F
    Transfus Apher Sci; 2003 Apr; 28(2):107-16. PubMed ID: 12679113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International views on universal leucodepletion: the perspective in Germany.
    Seitz MD
    Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.